Pulmonary Hypertension

Echocardiographic Ratio Shows Pre- and Post-Capillary Pulmonary Hypertension - The Cardiology Advisor Echocardiographic Ratio Shows Pre- and Post-Capillary Pulmonary Hypertension - The Cardiology Advisor Posted: 25 Jun 2019 01:00 AM PDT In patients with pulmonary hypertension (PH), echocardiographic pulmonary to left atrial global strain ratio accurately discriminated between pre-capillary and post-capillary PH, according to a study published in the International Journal of Cardiology . Researchers evaluated the ability of echocardiographic pulmonary to left atrial global strain ratio to differentiate pre-capillary and post-capillary PH to see whether echocardiographic pulmonary to left atrial ratio or echocardiographic pulmonary to left atrial global strain ratio had a superior diagnostic capacity. Patients with unexplained dyspnea or heart failure who were referred for right heart catheterization were included in this study. Transthor...

Echocardiographic Ratio Shows Pre- and Post-Capillary Pulmonary Hypertension - The Cardiology Advisor Echocardiographic Ratio Shows Pre- and Post-Capillary Pulmonary Hypertension - The Cardiology Advisor Posted: 25 Jun 2019 01:00 AM PDT In patients with pulmonary hypertension (PH), echocardiographic pulmonary to left atrial global strain ratio accurately discriminated between pre-capillary and post-capillary PH, according to a study published in the International Journal of Cardiology . Researchers evaluated the ability of echocardiographic pulmonary to left atrial global strain ratio to differentiate pre-capillary and post-capillary PH to see whether echocardiographic pulmonary to left atrial ratio or echocardiographic pulmonary to left atrial global strain ratio had a superior diagnostic capacity. Patients with unexplained dyspnea or heart failure who were referred for right heart catheterization were included in this study. Transthor...

Grant Will Award Up to $1 Million in Pulmonary Hypertension Research - The Cardiology Advisor Grant Will Award Up to $1 Million in Pulmonary Hypertension Research - The Cardiology Advisor Posted: 31 May 2019 12:00 AM PDT Pulmonary Hypertension Accelerated Bayer Awards, a new program launched by Bayer US, will award up to $1 million in grants to support clinical research in pulmonary hypertension, with a focus in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension . Grant applications will be open to physician practitioners and nonphysicians in the United States starting May 28 through June 30, 2019. Applicants will be expected to submit letters of intent with a short proposal that will be reviewed by an independent Grants Review Committee of 6 to 8 leading medical experts. After the initial evaluation, applicants will be invited to submit a full proposal by August 31, 2019. The applications can be submitted ...

PAH Patients' Poor Adherence to PDE-5i Linked to Adverse Effects - Pulmonary Hypertension News PAH Patients' Poor Adherence to PDE-5i Linked to Adverse Effects - Pulmonary Hypertension News Posted: 24 Jun 2019 07:00 AM PDT Adverse effects are associated with poor adherence to phosphodiesterase-5 inhibitors (PDE-5I) as treatment for patients with pulmonary arterial hypertension (PAH) treated via an integrated care model at an academic institution. Hospitalization events, out-of-pocket costs and frequency of dosing did not play a role, a study shows. Led by researchers at Tennessee's Vanderbilt University Medical Center , the study, " High Rates of Medication Adherence in Patients with Pulmonary Arterial Hypertension: An Integrated Specialty Pharmacy Approach, " was published in the journal PLOS ONE . PAH is a rare, progressive disorder characterized by high blood pressure (hyp...

PAH Patients' Poor Adherence to PDE-5i Linked to Adverse Effects - Pulmonary Hypertension News PAH Patients' Poor Adherence to PDE-5i Linked to Adverse Effects - Pulmonary Hypertension News Posted: 24 Jun 2019 07:00 AM PDT Adverse effects are associated with poor adherence to phosphodiesterase-5 inhibitors (PDE-5I) as treatment for patients with pulmonary arterial hypertension (PAH) treated via an integrated care model at an academic institution. Hospitalization events, out-of-pocket costs and frequency of dosing did not play a role, a study shows. Led by researchers at Tennessee's Vanderbilt University Medical Center , the study, " High Rates of Medication Adherence in Patients with Pulmonary Arterial Hypertension: An Integrated Specialty Pharmacy Approach, " was published in the journal PLOS ONE . PAH is a rare, progressive disorder characterized by high blood pressure (hyp...

Walking Together: My Sons' High School Graduation Was Extra Special - Pulmonary Hypertension News Walking Together: My Sons' High School Graduation Was Extra Special - Pulmonary Hypertension News Commonly prescribed drugs could increase the risk of dementia, says a new study - Medical Xpress Results Support Therapeutic Intra-vascular Ultrasound (TIVUS) for - Pulmonary Hypertension News Walking Together: My Sons' High School Graduation Was Extra Special - Pulmonary Hypertension News Posted: 24 Jun 2019 07:00 AM PDT My son's pulmonary arterial hypertension (PAH) was idiopathic, which means it developed suddenly with no known cause. He was healthy until he became symptomatic at 6 years old. Before then, we only brought him to the doctor for checkups and the occasional ear infection. He was an early walker who quickly mastered running and decided that was his preferred p...

Pulmonary Hypertension: How (and Why) to Embark on a Lower-Salt Lifestyle - Health Essentials from Cleveland Clinic Pulmonary Hypertension: How (and Why) to Embark on a Lower-Salt Lifestyle - Health Essentials from Cleveland Clinic Walking Together: My Sons' High School Graduation Was Extra Special - Pulmonary Hypertension News PAH Patients' Poor Adherence to PDE-5i Linked to Adverse Effects - Pulmonary Hypertension News Pulmonary Hypertension: How (and Why) to Embark on a Lower-Salt Lifestyle - Health Essentials from Cleveland Clinic Posted: 24 Jun 2019 05:00 AM PDT Most of us could probably stand to dial back our salt intake: According to the American Heart Association, the average American consumes twice the recommended amount per day. Advertising Policy Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Clevela...